Amarin Corp Plc (AMRN)

[VuBru]

Nice analysis Chas - thanks. R-It would predict that STRENGTH will likely show statistically significant benefits, but somewhat less than R-It. If Epanova is approved, it will not be until approx August of 2021 at the earliest (assuming priority review), based on latest study end date of Sept 2020. Might come down to an issue of marketing differentiation and price between V and epanova when 2022 rolls around.